31 January 2019 - Deborah Wilkes
Premium
Strides Pharma Science is selling its Australian business Arrow Pharmaceuticals to the Arrow-Apotex merged entity in a deal worth AUD394 million (USD285 million).
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.